You can read the full article at Sustained weight loss following 12-month pramlintide treatment as an adjunct to lifestyle intervention in obesity The objective of this study was to evaluate the long-term effectiveness and safety of pramlintide, a medication used for weight loss, in combination with a lifestyle intervention program (LSI).In a 4-month study, 411 obese participants were randomly assigned to receive different doses of pramlintide or a placebo, along with the LSI program
Our team is comprised of licensed doctors, each bringing a wealth of experience and specialized knowledge
Beyond the GI tract, semaglutide has been associated with fatigue, dizziness, headaches, and changes in taste perception
References [1] National Library of Medicine, Pentadecapeptide BPC 157 Enhances the Growth Hormone Receptor Expression in Tendon Fibroblasts, Chang, C., Tsai, W, Hsu, Y, Pang, J.S., 2014 [2] National Library of Medicine, Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review, Vasireddi, N., Hahamyan, H., Salata, M., Karns, M., Calcei, J., Voos, J., Apostolakos, J., July 2025 [3] National Library of Medicine, Pentadecapeptide BPC 157 Enhances the Growth Hormone Receptor Expression in Tendon Fibroblasts, Chang, C., Tsai, W., Hsu, Y., Pang, JS., November 2014
Pernicious Anaemia used to prove fatal (thats what pernicious means), but in the 1920s it was found that giving patients large amounts of liver meant that the patient could be kept alive, though his or her quality of life was compromised
